Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Hanerxi Medical

Request full access

Hanerxi develops adjustable precision pen injectors for drug delivery, specifically designed for managing chronic conditions and diseases

Suzhou Shi, ChinaFounded 2014Biotech & Life Sciences

About Hanerxi Medical

Hanerxi Medical, officially Suzhou Hanerxi Medical Device Development Co., Ltd., was established in 2014 and is headquartered in Suzhou, China. The company operates in the therapeutic devices industry, focusing on the development and manufacturing of injector pens for medical use. Hanerxi positions itself as a research and development-driven enterprise, holding independent intellectual property rights for its injection pen technology in China.

The company's product portfolio is designed to facilitate the self-administration of drugs for chronic diseases, aiming to provide patients with safer and more convenient treatment options. Hanerxi has developed 25 different products, including both reusable and disposable pen injectors. These devices are compatible with a wide range of biologic preparations packaged in cartridge bottles or pre-filled syringes. Specific applications include injectors for Insulin, GLP-1, Liraglutide, Semaglutide, growth hormone, interferon, and Gonal-F. The business model centers on the research, development, marketing, and distribution of these injection pens. Over the years, the company has secured funding from investors such as Fuzhe Capital, Herui Venture Capital, and Zhejiang State-Owned Capital Operation.

To support its growth, Hanerxi has expanded its operational footprint significantly. In 2019, it established a wholly-owned subsidiary in Kunshan, which serves as a pilot and small-scale production center, featuring China's first fully automated injection pen production and testing line with a reported annual capacity of 24 million units. A major expansion occurred in 2024 with the establishment of another subsidiary in Lishui, Zhejiang. This large-scale production facility, with a planned annual capacity of 600 million units, represents a substantial investment aimed at meeting growing demand.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
21.3/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotechnology, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2C
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jul 2024 $28M $110M Zhejiang FuZhe Capital Management ↗
SERIES AEquity / VC Dec 2021 $1.4M $5.5M Undisclosed —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Hanerxi Medical website traffic

Latest recorded traffic for Hanerxi Medical is 950 monthly website visits, up 120.9% over the last three months.

Latest monthly visits950 3-month web change+120.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Hanerxi Medical in the Suzhou Shi ecosystem

Live from Dealroom

The Hanerxi Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Zhejiang FuZhe Capital Management
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Suzhou Shi HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Hanerxi Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hanerxi Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.